Life Sciences Investor Forum today announced that the presentations from the December 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.

REGISTER OR LOGIN AT:  https://bit.ly/2Wqsir2

December 17th Presenting Companies:

Company Name Ticker(s)
Kane Biotech Inc. OTCQB: KNBIF | TSX-V: KNE
Theralase Technologies Inc. OTCQB: TLTFF | TSX-V: TLT
Caladrius Biosciences, Inc. NASDAQ: CLBS
Pressure BioSciences, Inc. OTCQB: PBIO
HLS Therapeutics Inc. TSX: HLS
Bionexus Gene Lab Corp. OTCQB: BGLC
VolitionRx Limited NYSE AMERICAN: VNRX
XPhyto Therapeutics Corp. OTCQB: XPHYF | CSE: XPHY | FSE: 4XT
Avicanna Inc. OTCQX: AVCNF | TSX: AVCN

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.

About Life Sciences Investor ForumLife Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACTLife Sciences Investor ForumJohn M. ViglottiSVP Corporate Services, Investor Access(212) 220-2221johnv@lifesciencesinvestorforum.com

HLS Therapeutics (TSX:HLS)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse HLS Therapeutics
HLS Therapeutics (TSX:HLS)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse HLS Therapeutics